PUBLICATIONS AND PRESENTATIONS

Prakash A., Lee A., Sclesi B., Cripps A. Effects of Next-Generation Sequencing on Lung Cancer Survivorship in Rural versus Urban Populations. Binaytara Foundation’s Precision Oncology Summit. October 2023.

Cripps A., Clinton N., Eller A. Breaking Down Barriers in Access to Biomarker Testing. Health Equity Summit Amerisource Bergen/Cencora. Indianapolis, Indiana. September 2023.

Cripps A., Farmer L., Smith C. Payer Engagement and Pathways. General Session Exchange Meeting Amerisource Bergen. San Diego, California. May 2023.

Kelley R., Hwang J., Magbanua M., Watt L., Beumer J., Christner S., Baruchel S., Fong L., Yeh B., Moore A., Ko A., Korn W., Rajpal S., Park J., Tempero M., Venook A., Bergsland E. A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer. 2013 Oct 1; 109(7): 1725–1734.

Thomas S., Aggarwal R., Jahan T., Ryan C., Troung T., Cripps AM., Raha P., Thurn KT., Chen S., Grabowsky JA., Park J., Hwang J., Daud A., Munster PN. A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma. Ann Oncol. 2016 Feb 21.

Munster P., Moore A., Ismail-Khan R., Cox C., Lacevic M., Gross-King M., Xu P., Carter B., Minton S. Randomized trial using the GnRH agonist triptorelin for the preservation of ovarian function during (neo) adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012 Feb 10;30(5):533-8.

Mukhtar R., Moore A., Nseyo O., Au A., Baehner F., Moore D., Campbell M., Esserman L.

Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011 Nov;130(2):635-44.

Thurn R., Thomas S., Moore A., Munster P. Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Future Oncol. 2011 Feb;7(2):263-83.

Mukhtar R., Moore A., Tandon V., Nseyo O., Au A., Baehner F., Adisa A., Eleweke N., Olopade O., Moore D., Campbell M., Esserman L. Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness. ASCO 2011 abstract #1043.

Moore A., Magbanua M., Scott J., Moore D., Alvarado M., Esserman L., Park J. Simultaneous quantitative assessment of tumor cells in blood and bone marrow in primary breast cancer patients. Poster Discussion San Antonio Breast Cancer Symposium. December 2008.

Cripps M., Moore A. Approach to Drowning and Near-Drowning. (Toy, Liu, Ed. New York, Lange 2005). Case Files in Emergency Medicine. 367-75.

Moore A. Unusual Manifestations of Leukemia. Poster Presentation American College of Physicians, Monterey, California. November 2006.